Analyst Recommendations

RBC Capital analyst issues OUTPERFORM recommendation for J on February 4, 2026 01:35PM ET. The previous analyst recommendation was Outperform.J was trading at $132.91 at issue of the...

February 4, 2026   J -0.05%

Morgan Stanley analyst issues OVERWEIGHT recommendation for ETN on February 4, 2026 01:38PM ET. The previous analyst recommendation was Overweight.ETN was trading at $362.53 at issue of the...

February 4, 2026   ETN -0.96%

Morgan Stanley analyst issues OVERWEIGHT recommendation for CMG on February 4, 2026 01:34PM ET. The previous analyst recommendation was Overweight.CMG was trading at $39.175 at issue of the...

February 4, 2026   CMG 1.18%

Oppenheimer analyst issues OUTPERFORM recommendation for GAIN on February 4, 2026 01:35PM ET. The previous analyst recommendation was Outperform.GAIN was trading at $13.74 at issue of the analyst...

February 4, 2026   GAIN -2.22%

RBC Capital analyst issues OUTPERFORM recommendation for MRCY on February 4, 2026 01:35PM ET. The previous analyst recommendation was Outperform.MRCY was trading at $99.28 at issue of the...

February 4, 2026   MRCY -0.97%

Oppenheimer analyst issues OUTPERFORM recommendation for PNR on February 4, 2026 01:33PM ET. The previous analyst recommendation was Outperform.PNR was trading at $94.79 at issue of the analyst...

February 4, 2026   PNR -2.20%

Lake Street analyst issues BUY recommendation for TATT on February 4, 2026 01:43PM ET. The previous analyst recommendation was Buy.TATT was trading at $48.72 at issue of the...

February 4, 2026   TATT -9.43%

RBC Capital analyst issues OUTPERFORM recommendation for EPD on February 4, 2026 01:44PM ET. The previous analyst recommendation was Outperform.EPD was trading at $34.63 at issue of the...

February 4, 2026   EPD 0.17%

RBC Capital analyst issues OUTPERFORM recommendation for EMR on February 4, 2026 01:45PM ET. The previous analyst recommendation was Outperform.EMR was trading at $152.1 at issue of the...

February 4, 2026   EMR -1.37%

Cowen & Co. analyst issues BUY recommendation for CPRI on February 4, 2026 01:44PM ET. The previous analyst recommendation was Buy.CPRI was trading at $20.08 at issue of...

February 4, 2026   CPRI -2.78%